Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma


Eren M. H., GÜNGEL H., Altan C., Pasaoglu I. B., Sabanci S.

Journal of Ocular Pharmacology and Therapeutics, cilt.28, sa.4, ss.381-386, 2012 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 4
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1089/jop.2011.0105
  • Dergi Adı: Journal of Ocular Pharmacology and Therapeutics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.381-386
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Purpose: To compare the efficacy and safety of dorzolamide hydrochloride 2%/timolol maleate 0.5% fixed combination (DTFC) with latanoprost 0.005%/timolol maleate 0.5% fixed combination (LTFC) on diurnal intraocular pressure (IOP) in patients with primary open-angle glaucoma. Methods: Thirty-three primary open-angle glaucoma patients with IOP of 22-32mmHg measured at any time were included. Patients were randomized to either DTFC twice daily or latanoprost 0.005%/timolol maleate 0.5% fixed combination (LTFC) once a day in the evening. After a 6-week treatment period with each combination, IOP were measured every 4h during 24h (first diurnal curve) and after 6 weeks of washout period, the patients were switched to the other treatment for 6 weeks of the second diurnal curve. Results: The mean baseline IOP was 25.09±2.8mmHg. After the treatment period, mean diurnal IOP was statistically lower with LTFC (16.3mmHg) than with DTFC (17.3mmHg), and the peak IOP value was 18.5mmHg with LTFC and 19.9±2.6mmHg with DTFC (P<0.05). No significant side effects were reported except stinging and bitter taste with the DTFC group. Conclusion: Mean diurnal IOP and peak IOP were lower with LTFC than with DTFC in patients with primary open-angle glaucoma. © Copyright 2012, Mary Ann Liebert, Inc.